tiprankstipranks
Castle Biosciences (CSTL)
NASDAQ:CSTL
US Market

Castle Biosciences (CSTL) Income Statement

Compare
420 Followers

Castle Biosciences Income Statement

Last quarter (Q3 2024), Castle Biosciences's total revenue was $85.78M, an increase of 39.50% from the same quarter last year. In Q3, Castle Biosciences's net income was $2.27M. See Castle Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 219.79M$ 137.04M$ 94.08M$ 62.65M$ 51.87M
Gross Profit
$ 174.81M$ 105.03M$ 78.26M$ 52.96M$ 44.55M
Operating Expenses
$ 242.78M$ 196.17M$ 118.34M$ 59.51M$ 37.23M
Depreciation and Amortization
$ 12.33M$ 10.54M$ 3.41M$ 472.00K$ 358.00K
EBITDA
$ -45.02M$ -58.34M$ -36.60M$ -7.09M$ 7.69M
Operating Income
$ -67.98M$ -91.14M$ -40.08M$ -6.54M$ 4.71M
Other Income/Expenses
$ 10.61M$ 3.95M$ 67.00K$ -3.66M$ -1.98M
Pretax Income
$ -57.37M$ -68.90M$ -40.01M$ -10.20M$ 5.35M
Net Income
$ -57.47M$ -67.14M$ -31.29M$ -10.28M$ 5.28M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.14$ -2.58$ -1.24$ -0.54$ 0.35
Diluted EPS
$ -2.14$ -2.58$ -1.24$ -0.54$ -0.21
Weighted Average Shares Outstanding
26.80M 26.05M 25.14M 18.93M 8.58M
Weighted Average Shares Outstanding (Diluted)
26.80M 26.05M 25.14M 18.93M 8.66M
Currency in USD

Castle Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis